Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease
RecruitingNCT06920134Phase: NAStarted 2025-07-03
Summary
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkin
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
90 Years
Locations
CHUVLausanne, Canton of Vaud, Switzerland
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06920134